Research Insight LLC
Quick facts
Marketed products
- Cequa · Other
- Dexycu intracameral dexamethasone · Ophthalmology
Dexycu is an intracameral corticosteroid that reduces inflammation in the anterior chamber of the eye following cataract surgery. - Lifitegrast 5% Ophthalmic Solution · Ophthalmology
Lifitegrast is a lymphocyte function-associated antigen-1 (LFA-1) antagonist that blocks T-cell adhesion and infiltration into ocular tissues to reduce inflammation in dry eye disease.
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:
Frequently asked questions about Research Insight LLC
What are Research Insight LLC's marketed drugs?
Top marketed products include Cequa, Dexycu intracameral dexamethasone, Lifitegrast 5% Ophthalmic Solution.
Related
- Cequa · Other
- Dexycu intracameral dexamethasone · Ophthalmology
- Lifitegrast 5% Ophthalmic Solution · Ophthalmology
- Sector hub: All tracked pharma companies